ScholarIQanswers from OpenAlex

Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease

PaperCitations, authors & open-access status

Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease have?

ScholarIQcitation count

Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease has 114 citations in the OpenAlex counts ScholarIQ stores.

When was Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease published?

ScholarIQyear

Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease has 2013 year in the ScholarIQ index.

What is the open-access status of Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease?

ScholarIQoa status

Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease has closed oa status in the ScholarIQ index.

What is the DOI of Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease?

ScholarIQdoi

The DOI for Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease is on the source record.

What is the PMID of Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease?

ScholarIQpmid

The PMID for Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease is on the source record.

What is the OpenAlex record for Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease?

ScholarIQopenalex

The OpenAlex for Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial